Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elżbieta Kaczmarek is active.

Publication


Featured researches published by Elżbieta Kaczmarek.


Archives of Oral Biology | 2011

Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes.

Anna Surdacka; Edyta Ciężka; Maria Pioruńska-Stolzmann; Ewa Wender-Ożegowska; Katarzyna Korybalska; Edyta Kawka; Elżbieta Kaczmarek; Janusz Witowski

OBJECTIVEnBoth pregnancy and diabetes are thought to predispose to the impairment of oral health. As saliva contributes to oral homeostasis, we have characterised its properties and flow rate in pregnant women with or without diabetes.nnnDESIGNnUnstimulated whole mixed saliva was collected from 63 women in the first trimester of pregnancy and analysed for the concentration of selected antioxidants, cytokines, and growth factors.nnnRESULTSnPregnant women with diabetes were found to have markedly increased indexes of caries activity, plaque formation, gingival and periodontal status, as well as increased salivary antioxidant capacity and pro-inflammatory cytokine levels. These changes were more pronounced in patients with long-term disease and systemic diabetic complications, but only partly correlated with the level of blood glycated haemoglobin. Of the cytokines examined, salivary VEGF and HGF concentrations in diabetic pregnant women correlated in a positive and negative manner, respectively, with the prevalence of caries. Moreover, VEGF levels in this group correlated inversely with the probing depth and clinical attachment levels. All such associations did not occur in healthy individuals. In contrast, the salivary pH and flow rate correlated inversely with several parameters of caries and plaque formation irrespectively of whether the pregnant women were diabetic or not.nnnCONCLUSIONSnDiabetes in pregnant women significantly changes saliva properties, which may contribute to accelerated deterioration of the oral status in this population.


International Journal of Colorectal Disease | 2014

Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study

Lukasz Krokowicz; Zoran Stojcev; Bartosz Filip Kaczmarek; Wojciech Kociemba; Elżbieta Kaczmarek; Jarosław Walkowiak; Piotr Krokowicz; Michał Drews; Tomasz Banasiewicz

BackgroundMicroencapsulated sodium butyrate (MSB) has been previously associated with anti-inflammatory and regenerative properties regarding large bowel mucosa. We aimed to examine a role of MSB in patients with diverticulosis, hypothesizing its potential for reduction of diverticulitis episodes and diverticulitis prevention.MethodsSeventy-three patients with diverticulosis (diagnosed in colonoscopy or/and barium enema or/and CT colography) were recruited for the study and randomized. The investigated group was administered MSB 300xa0mg daily; the control group was administered placebo. After 12xa0months, a total of 52 patients completed the study and were subject to analysis (30 subjects and 22 controls). During the study, the number of episodes of diverticulitis (symptomatic diagnosis with acute pain, fever, and leukocytosis), hospitalizations, and surgery performed for diverticulitis were recorded. Additionally, a question regarding subjective improvement of symptoms reflected changes in quality of life during the analysis.ResultsAfter 12xa0months, the study group noted a significantly decreased number of diverticulitis episodes in comparison to the control group. The subjective quality of life in the study group was higher than in the control group. There were no side effects of the MSB during the therapy.ConclusionsMSB reduces the frequency of diverticulitis episodes, is safe, and improves the quality of life. It can play a role in the prevention of diverticulitis.


Journal of Clinical Pathology | 2011

Changes of B and T lymphocytes and selected apopotosis markers in Hashimoto's thyroiditis

Elżbieta Kaczmarek; Katarzyna Lacka; Donata Jarmołowska-Jurczyszyn; Anna Sidor; Przemysław Majewski

The aim was to assess changes of B and T lymphocytes and selected apoptotic markers in Hashimoto thyroiditis (HT) cases on the basis of quantitative immunohistochemical studies (CD20, CD43, CD8, Bcl-2, caspase-3). The control group comprised colloid goitres without inflammatory infiltrate taken from 10 female patients. Thyroid specimens were obtained retrospectively from 40 patients. The immunohistochemical reactions were subject to quantitative evaluation performed using image-processing methods, including a spatial visualisation of the markers expression. The percentage of Bcl-2 reactions in HT (mean 3.65%, SD 2.94%) was significantly lower than in the control group (mean 13.99%, SD 5.04%), while the thyroid follicles in HT samples exhibited a higher degree of staining for caspase-3 (mean 1.10%, SD 1.03%) in contrast to normal control tissues (mean 0.48%, SD 1.02%). The results from this study indicate that apoptosis plays a major role in the patogenesis of autoimmune thyroid diseases containing the main pathogenic events in the lesion of thyroid follicular cells in HT. Moreover, the reactivity of CD43 and CD20 was significantly higher in Hashimoto disease, while CD8 was not significantly different from the control group.


Nephrology Dialysis Transplantation | 2010

Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis

Ilona Idasiak-Piechocka; Andrzej Oko; Elżbieta Pawliczak; Elżbieta Kaczmarek; Stanisław Czekalski

BACKGROUNDnThe effects of tumor necrosis factor α (TNF α), a potent proinflammatory cytokine, in the kidneys are mediated by two membrane receptors (TNFR), TNFR1 and TNFR2. The expression of both TNF and TNFRs increases in several kidney diseases and is associated with the shedding of the receptors out of the cell membranes. In an experimental model of glomerulonephritis (GN), elevated concentrations of TNFRs in serum and TNFRs excretion in urine were demonstrated. The aim of this study was evaluation of urinary excretion of TNFR1 and its relationship with the clinical markers of kidney injury in patients with GN. The value of basal urinary TNFR1 excretion as a prognostic indicator of the progression of kidney function impairment was also assessed.nnnMATERIAL AND METHODSnFifty-five patients with newly diagnosed, biopsy-proven primary GN were included in the study. In all patients, and in 20 healthy subjects, UTNFR1 was measured using an ELISA . In the patients, risk factors of the progression of impairment of kidney function (reduced eCcr, nephrotic syndrome, hypertension and intensity of morphological lesions in the kidneys) were evaluated. The appropriate treatment was then introduced and the patients were in follow-up for 4 years. The progression of kidney function impairment was defined as a reduction of eCcr > 5 mL/min/1.73 m2 /year during follow-up. The association of basal TNFR1 excretion with the progression was evaluated.nnnRESULTSnUrinary excretion of TNFR1 in the patients with GN (4039.2 ± 3801.5 pg/mgCr) was greater than in the healthy subjects (1358.9 ± 927.8 pg/mgCr, P < 0,00002). A significant negative correlation between TNFR1 excretion and eCcr (Sr=0.464, P < 0.01) and a positive correlation between TNFR1 excretion and proteinuria (Sr = 0,463, P < 0.01) were found. In 13 patients, a marked reduction of eCcr was observed during follow-up. Logistic regression analysis revealed that TNFR1 excretion > 3863.3 pg/mgCr predicts progression of renal function impairment along with advanced interstitial fibrosis in the kidney biopsy specimens at presentation.nnnCONCLUSIONnMarkedly elevated urinary TNFR1 excretion may be considered as a good marker of an activated TNFα-pathway in patients with newly diagnosed GN and as a potentially modifiable risk factor of progressive kidney function impairment.


Histopathology | 2005

Vascular endothelial growth factor (VEGF‐C1)‐dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach

D Ostalska-Nowicka; J Zachwieja; M Nowicki; Elżbieta Kaczmarek; A Siwińska; Martin Witt

Aims :u2002To analyse expression and distribution of vascular endothelial growth factor (VEGF‐C1), podocalyxin and synaptopodin within renal tissue in nephrotic syndrome glomerulopathies in children.


International Journal of Colorectal Disease | 2011

The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP

Tomasz Banasiewicz; Ryszard Marciniak; Elżbieta Kaczmarek; Piotr Krokowicz; Jacek Paszkowski; Aleksandra Lozynska-Nelke; Piotr Gronek; Andrzej Plawski; Michał Drews

PurposeThe main operative method in familial adenomatous polyposis (FAP) patients is restorative proctocolectomy with “J”-shaped pouch and temporary loop ileostomy. The aim of the study was the analysis of the frequency of the dysplasia and inflammation in the intestinal pouch and prognosis of the clinical course in FAP patients after restorative proctocolectomy.MethodsA group of 165 FAP patients (86 females and 79 males, mean age 22.49u2009±u200912) subjected to a restorative proctocolectomy in the years 1985–2009 was analyzed. Clinical data coming from follow-up observation in the period of 2004–2009 were evaluated. In all patients, clinical examination and endoscopy with polypectomy and/or biopsy of pouch mucosa were done.ResultsThe mean time of pouchitis occurrence after an ileal pouch-anal anastomosis was 6xa0months. Mean time for low-grade dysplasia was 14xa0months. The time difference of low-grade dysplasia after the above procedure as compared to pouchitis alone was substantial. Mean time for high-grade dysplasia was 16xa0months and for neoplasia even 19xa0months. It was estimated that early pouchitis happening within the first year after surgery occurs in 5% of patients, low-grade dysplasia 4xa0years later in 7% of cases, high-grade dysplasia 7xa0years later in around 10% of patients and neoplasia 14xa0years after surgery in 15% of cases.ConclusionsIn conclusion, the Polyposis Registry encompassing whole country is the best way of controlling FAP patients. The regular lifelong endoscopic monitoring gives the opportunity of the early detection of the dysplasia and can protect against neoplasia.


Journal of Molecular Histology | 2008

Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification

Elżbieta Kaczmarek; Katarzyna Lacka; Przemysław Majewski; Pawel Trzeciak; Agnieszka Górna; Donata Jarmołowska-Jurczyszyn; Andrzej Kluk

The aim of the paper was to apply a method for quantitative assessment of proliferation and apoptosis markers, based on their 3D visualization, in cases of parathyroid adenoma and hyperplasia. Material was obtained from 49 patients (32 females and 17 males) with primary hyperparahyroidism. Quantitative immunohistochemistry studies of Ki-67, proliferating cell nuclear antigen (PCNA) and bcl-2 were performed on digital microscopy images with the use of 3D visualization. The use of spatial visualization method allowed us to perform objective quantitative assessment of the studied immunohistochemical markers. The average cell nuclear fraction of Ki67+ was 1.8% in hyperplasia and 1.9% in adenoma cases while 3.5% in the controls. The highest expression of PCNA was found in parathyroid hyperplasia (22.9%) and significantly decreased in adenoma (12.5%) and in the control group (16.8%). The lower expression of bcl-2 in hyperplasia cases (mean area fraction of 0.172 per 1xa0μm2, in contrast to 0.643 in adenomas and 0.648 in control) suggested that principal cells can be ready for apoptosis and may confirm the important role of bcl-2 protein in etiopathogenesis of hyperplasia of the parathyroid gland while PCNA might be a useful marker for differentiating adenoma from early hyperplasia in primary hyperparahyroidism cases.


Histopathology | 2007

Immunohistochemical detection of galectin‐1 in renal biopsy specimens of children and its possible role in proteinuric glomerulopathies

D Ostalska-Nowicka; J Zachwieja; M Nowicki; Elżbieta Kaczmarek; A Siwińska; Martin Witt

Aims:u2002 Galectin‐1 is an endogenous lectin that specifically binds to β‐galactoside structures. It has been associated with developmental mechanisms ranging from differentiation to apoptosis and exerts immunoregulatory functions in autoimmune diseases. The aim was to determine the immunohistochemical expression of galectin‐1 in renal biopsy specimens of children with primary idiopathic proteinuric glomerulopathies.


Journal of Clinical Pathology | 2006

Ezrin—a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach

Danuta Ostalska-Nowicka; Jacek Zachwieja; Michał Nowicki; Elżbieta Kaczmarek; Aldona Siwińska; Martin Witt

Background: Minimal change disease (MCD) and diffuse mesangial proliferation (DMP) are the most common pathomorphological forms of nephrotic syndrome glomerulopathies in children. The clinical course of DMP can be characterised by either DMP-sensitivity (DMP-S) or DMP-resistance (DMP-R) to steroids, resulting in an unfavourable course of the glomerulopathy. Although the clinical processes of DMP-S and DMP-R are initially identical, resistance to steroids may be foreseen by the immunohistochemical expression of cytoskeleton-associated proteins in podocytes. Aims: To estimate the immunohistochemical expression of ezrin in children with MCD, DMP and focal segmental glomerulosclerosis (FSGS) and to evaluate its usefulness in predicting resistance to steroids. Materials and methods: Renal biopsy specimens of patients with MCD (nu200a=u200a15), DMP (nu200a=u200a16) and FSGS (nu200a=u200a6) were taken. The control tissue consisted of normal-appearing cortex taken from kidneys resected for localised neoplasms (nu200a=u200a6). The indirect immunohistochemical protocol for the use of a monoclonal antibody directed against ezrin was used. Results: The immunohistochemical expression of ezrin in cases progressively reduced from MCD to DMP-S to DMP-R to FSGS. Except for DMP-R and FSGS (p>0.05), the difference in ezrin expression in podocytes was significant. Conclusion: Ezrin can be a potent marker of podocyte injury (podocytopathy) and may help in the histological qualification of MCD, DMP and FSGS. The increased permeability of the filtration barrier in steroid-resistant and proteinuric glomerulopathies may be a consequence of subcellular changes in podocyte-associated proteins following decreased expression of ezrin.


Journal of Clinical Hypertension | 2015

Association of PPAR-γ2 and β3-AR Polymorphisms With Postmenopausal Hypertension.

Bogna Grygiel-Górniak; Elżbieta Kaczmarek; Maria Mosor; Juliusz Przysławski; Jerzy Z. Nowak

The aim of this study was to test the association of peroxisome proliferator‐activated receptor (PPAR‐γ2) (Pro12Ala, C1431T) and β3‐AR (Trp64Arg) polymorphisms with metabolic, nutritional, and blood pressure parameters in 271 postmenopausal women (151 hypertensive and 120 normotensive controls). The TaqMan genotyping assay and restriction fragment length polymorphism methods were used to determine the distributions of selected alleles and genotype frequencies. Nutritional status was determined by a bioimpedance method and dietary habits were assessed via 7‐day dietary recall. The distribution of selected genotypes and allele frequencies did not differ between hypertensive women and normal controls after analysis by chi‐square test. The postmenopausal hypertensive women were older and had higher body fat mass, serum glucose, and triglyceride levels. The cluster analysis showed that the hypertensive group with Pro12Pro genotype had highest pulse pressure and mean arterial pressure values when compared with Pro12Ala patients. In the logistic regression analysis, blood glucose (Pro12Ala polymorphism) and energy intake (C1431Tand T1431T polymorphisms) determined hypertension.

Collaboration


Dive into the Elżbieta Kaczmarek's collaboration.

Top Co-Authors

Avatar

Agnieszka Seraszek-Jaros

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Justyna Gornowicz-Porowska

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Marian Dmochowski

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Monika Bowszyc-Dmochowska

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Aldona Kasprzak

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Bogna Grygiel-Górniak

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Juliusz Przysławski

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Maria Mosor

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Michał Drews

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Paweł Bartkiewicz

Poznan University of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge